Statistics for Optinose (id:8237 OPTN)

Valuation metrics

Market cap

58.07M

Enterprise value

-6,664,072.00

Trailing P/E (ttm)

-1.15

Forward P/E

-4.28

PEG ratio

-4.28

Price/Sales (ttm)

0.77

Price/Book (mrq)

-1.56

Enterprise Value/Revenue

-0.09

Enterprise Value/EBITDA

0.35

Overview

Shares outstanding

150.78M

Float

106.30M

Shares short

8.57M

% Held by insiders

0.06%

% Held by institutions

0.77%

Average volume (10 days)

1.36M

Average volume (90 days)

Price summary

52-Week low

0.32

52-Week high

2.10

52-Week change

-237.88%

Beta

-0.07

50-Day moving average

0.73

200-Day moving average

1.09

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-41.16%

Operating margin

-10.04%

Operational effectiveness

Return on assets

-10.32%

Return on equity

40.97%

Income statement

Revenue (ttm)

0.55

Revenue per share (ttm)

0.55

Quarterly revenue growth (yoy)

Gross profit (ttm)

62.35M

EBITDA

-18,856,000.00

Net income to common (ttm)

-31,148,000.00

Diluted EPS (ttm)

-0.34

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

82.50M

Total cash per share (mrq)

0.47

Total debt (mrq)

0.00

Total Debt/Equity (mrq)

0.00

Current ratio (mrq)

50.80%

Book value per share (mrq)

-0.24

Cash flow

Cash flow statement

-14,342,000.00

Levered free cash flow (LFCF)

-35,483,000.00